From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas. (Q33929813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Olivier Manches

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

M C Jacob

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J P Molens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J C Bensa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Plumas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

247-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Role of B cells in antigen presentation of the hepatitis B core

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

How B and T cells talk to each other

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Functional significance of varied quantitative and qualitative expression of HLA-A2.1 antigens in determining the susceptibility of cells to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Protection from natural killer cell-mediated lysis by HLA-G expression on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Expression of HLA G in human tumors is not a frequent event.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Idiotypic DNA vaccines against B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Idiotypic vaccine for treatment of human B-cell lymphoma. Construction of IgG variable regions from single malignant B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CTLA-4 ligation blocks CD28-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Molecular basis of T cell inactivation by CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Fas ligation induces apoptosis of CD40-activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Interleukin 1: an immunological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087016

10.3109/10428190009087016

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference